“Sglt2 Inhibitors And The Clinical Conundrum Of Heart Failure With Preserved Ejection Fraction”. 2022. Journal of Pharmaceutical Negative Results, November, 2200-2204. https://doi.org/10.47750/pnr.2022.13.S04.273.